Index
1 Market Overview of Neuropathic Pain Drugs
1.1 Neuropathic Pain Drugs Market Overview
1.1.1 Neuropathic Pain Drugs Product Scope
1.1.2 Neuropathic Pain Drugs Market Status and Outlook
1.2 Global Neuropathic Pain Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuropathic Pain Drugs Market Size by Region (2018-2029)
1.4 Global Neuropathic Pain Drugs Historic Market Size by Region (2018-2023)
1.5 Global Neuropathic Pain Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuropathic Pain Drugs Market Size (2018-2029)
1.6.1 North America Neuropathic Pain Drugs Market Size (2018-2029)
1.6.2 Europe Neuropathic Pain Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Neuropathic Pain Drugs Market Size (2018-2029)
1.6.4 Latin America Neuropathic Pain Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Neuropathic Pain Drugs Market Size (2018-2029)
2 Neuropathic Pain Drugs Market by Type
2.1 Introduction
2.1.1 Tricyclic Anti-Depressants Anticonvulsants
2.1.2 Serotonin-Norepinephrine Reuptake Inhibitor
2.1.3 Capsaicin Cream
2.1.4 Local Anaesthesia
2.1.5 Opioids
2.1.6 Steroids
2.1.7 Others
2.2 Global Neuropathic Pain Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuropathic Pain Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Neuropathic Pain Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuropathic Pain Drugs Revenue Breakdown by Type (2018-2029)
3 Neuropathic Pain Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Neuropathic Pain Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuropathic Pain Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Neuropathic Pain Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuropathic Pain Drugs Revenue Breakdown by Application (2018-2029)
4 Neuropathic Pain Drugs Competition Analysis by Players
4.1 Global Neuropathic Pain Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuropathic Pain Drugs as of 2022)
4.3 Date of Key Players Enter into Neuropathic Pain Drugs Market
4.4 Global Top Players Neuropathic Pain Drugs Headquarters and Area Served
4.5 Key Players Neuropathic Pain Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Neuropathic Pain Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Neuropathic Pain Drugs Products, Services and Solutions
5.1.4 Pfizer Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Neuropathic Pain Drugs Products, Services and Solutions
5.2.4 Johnson & Johnson Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Neuropathic Pain Drugs Products, Services and Solutions
5.3.4 Sanofi Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Neuropathic Pain Drugs Products, Services and Solutions
5.4.4 GlaxoSmithKline Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Neuropathic Pain Drugs Products, Services and Solutions
5.5.4 Eli Lilly Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly Recent Developments
5.6 Bristol-Myers Squibb
5.6.1 Bristol-Myers Squibb Profile
5.6.2 Bristol-Myers Squibb Main Business
5.6.3 Bristol-Myers Squibb Neuropathic Pain Drugs Products, Services and Solutions
5.6.4 Bristol-Myers Squibb Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Bristol-Myers Squibb Recent Developments
5.7 Biogen
5.7.1 Biogen Profile
5.7.2 Biogen Main Business
5.7.3 Biogen Neuropathic Pain Drugs Products, Services and Solutions
5.7.4 Biogen Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Biogen Recent Developments
5.8 Baxter Healthcare
5.8.1 Baxter Healthcare Profile
5.8.2 Baxter Healthcare Main Business
5.8.3 Baxter Healthcare Neuropathic Pain Drugs Products, Services and Solutions
5.8.4 Baxter Healthcare Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Baxter Healthcare Recent Developments
5.9 Depomed
5.9.1 Depomed Profile
5.9.2 Depomed Main Business
5.9.3 Depomed Neuropathic Pain Drugs Products, Services and Solutions
5.9.4 Depomed Neuropathic Pain Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Depomed Recent Developments
6 North America
6.1 North America Neuropathic Pain Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neuropathic Pain Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuropathic Pain Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuropathic Pain Drugs Market Dynamics
11.1 Neuropathic Pain Drugs Industry Trends
11.2 Neuropathic Pain Drugs Market Drivers
11.3 Neuropathic Pain Drugs Market Challenges
11.4 Neuropathic Pain Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List